0001140361-15-045913.txt : 20151230
0001140361-15-045913.hdr.sgml : 20151230
20151230145002
ACCESSION NUMBER: 0001140361-15-045913
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20151230
DATE AS OF CHANGE: 20151230
EFFECTIVENESS DATE: 20151230
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solstice Biologics LLC
CENTRAL INDEX KEY: 0001564178
IRS NUMBER: 461223656
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-254171
FILM NUMBER: 151313296
BUSINESS ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-800-0800
MAIL ADDRESS:
STREET 1: 1700 OWENS STREET
STREET 2: SUITE 595
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
D
1
primary_doc.xml
X0707
D
LIVE
0001564178
Solstice Biologics LLC
1700 OWENS STREET
SUITE 595
SAN FRANCISCO
CA
CALIFORNIA
94158
415-800-0800
DELAWARE
None
None
Limited Liability Company
true
2012
Corey
Goodman
c/o Solstice Biologics LLC
1700 Owens Street, Suite 595
San Francisco
CA
CALIFORNIA
94158
Executive Officer
Director
Promoter
Mr. Goodman is the President, Chief Executive Officer and a member of the Board of Managers of the Issuer.
Robert
Adelman
c/o Solstice Biologics LLC
1700 Owens Street, Suite 595
San Francisco
CA
CALIFORNIA
94158
Director
Mr. Adelman is a member of the Board of Managers of the Issuer.
Curt
Bradshaw
c/o Solstice Biologics LLC
1700 Owens Street, Suite 595
San Francisco
CA
CALIFORNIA
94158
Executive Officer
Director
Promoter
Mr. Bradshaw is the Secretary and Treasurer and a member of the Board of Managers of the Issuer.
Steven
Dowdy
c/o Solstice Biologics LLC
1700 Owens Street, Suite 595
San Fransciso
CA
CALIFORNIA
94158
Director
Mr. Dowdy is a member of the Board of Managers of the Issuer.
John
Borgeson
c/o Solstice Biologics LLC
1700 Owens Street, Suite 595
San Francisco
CA
CALIFORNIA
94158
Executive Officer
Mr. Borgeson is the Assistant Secretary of the Issuer.
George
Rehm
c/o Solstice Biologics LLC
1700 Owens Street, Suite 595
San Francisco
CA
CALIFORNIA
94158
Director
Mr. Rehm is a member of the Board of Managers of the Issuer.
Pharmaceuticals
Decline to Disclose
- 06b
false
2015-12-15
false
true
true
Series A-4 Preferred Stock.
false
0
4000000
4000000
0
false
2
0
0
0
false
Solstice Biologics LLC
/s/ Corey Goodman
Corey Goodman
President and CEO of the Issuer
2015-12-30